In-Depth Research On:
Repros Therapeutics Inc. (RPRX)
Sign Up Now to Download a Free Research Report on RPRX
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Repros Therapeutics Inc.
Repros Therapeutics focuses on the development of small molecule drugs for major unmet medical needs that treat male and female reproductive disorders. The company now expects to provide clinical results from the first pivotal study of Androxal in the treatment of secondary hypogonadism in the third quarter of 2013.
Going forward ... (see research report)
